MedTrace Logo

Osteoporotic Precisely Screening Using Chest Radiograph and Artificial Neural Network (OPSCAN)

NCT05721157 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4912

Last updated 2023-07-11

No results posted yet for this study

Summary

Artificial Intelligence-assisted Diagnosis and Prognostication in Osteoporosis Using Chest X-ray

Conditions

Interventions

OTHER

AI-enabled Chest X-ray-based Screening Tool

Primary care clinicians in the intervention group had access to the report, which displayed whether the AI-Chest X-ray result was positive or negative.The system will send a message to corresponding physicians if positive finding.

Sponsors & Collaborators

  • National Defense Medical Center, Taiwan

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05721157 on ClinicalTrials.gov